With API R&D and manufacturing facilities in the USA and Europe, Cambrex can support your project in regulated, emerging and developing markets. We are in your neighbourhood, wherever you are.

Our LocationsTallinnPaulloWiesbadenKarlskogaCorporateHigh PointCharles City

Our locations

Cambrex has a presence in six locations globally, including a corporate headquarters in East Rutherford, NJ, USA and API development and manufacturing facilities in Charles City, Iowa, USA, Karlskoga, Sweden, Paullo (Milan), Italy, Tallinn, Estonia and Wiesbaden, Germany.

Regardless of location, our team of experts have a shared goal to use our technologies and expertise to accelerate your small molecule therapeutics into the market.